Fresenius Medical Care AG (ETR:FME – Get Free Report)’s share price crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of €42.56 ($47.29) and ...
We recently published a list of 8 Most Undervalued Healthcare Stocks to Buy According to Analysts. In this article, we are ...
We recently published a list of 12 Best German Stocks to Buy According to Hedge Funds. In this article, we are going to take ...
A PharmaSphere Inc. subsidiary didn’t mislead the US Patent and Trademark Office to obtain the patent at the center of an ...
Fresenius, Danone and Proximus benchmarks shake off tariff turmoil â—† Range of new issue concessions needed â—† High orderbook attrition for those pushing hard on spread ...
On March 26, 2025, the FDA approved Fresenius Kabi’s denosumab biosimilars, CONEXXENCE® (denosumab-bnht) and BOMYNTRA® (denosumab-bnht), ...
Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...
Every high grade euro benchmark sized corporate bond sold this week but one traded wide of reoffer on Thursday, as global financial markets reelled from US tariffs. On Wednesday, US president Trump ...
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss ...
The FDA has approved two new denosumab biosimilars that are interchangeable with the reference medications Prolia and Xgeva, ...
HIS, ANI Pharmaceuticals, Pediatrix Medical, Fresenius Medical Care and LendingTree are part of the Zacks Screen of the Week article.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback